5-90807708-G-C
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_032119.4(ADGRV1):c.14943G>C(p.Gln4981His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000333 in 1,587,746 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_032119.4 missense
Scores
Clinical Significance
Conservation
Publications
- Usher syndrome type 2Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Usher syndrome type 2CInheritance: AR Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- febrile seizures, familial, 4Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AR Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_032119.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ADGRV1 | NM_032119.4 | MANE Select | c.14943G>C | p.Gln4981His | missense | Exon 73 of 90 | NP_115495.3 | ||
| ADGRV1 | NR_003149.2 | n.14959G>C | non_coding_transcript_exon | Exon 73 of 90 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ADGRV1 | ENST00000405460.9 | TSL:1 MANE Select | c.14943G>C | p.Gln4981His | missense | Exon 73 of 90 | ENSP00000384582.2 | ||
| ADGRV1 | ENST00000638510.1 | TSL:1 | n.2210G>C | non_coding_transcript_exon | Exon 9 of 26 | ||||
| ADGRV1 | ENST00000425867.3 | TSL:5 | c.3897G>C | p.Gln1299His | missense | Exon 21 of 38 | ENSP00000392618.3 |
Frequencies
GnomAD3 genomes AF: 0.00186 AC: 283AN: 152238Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000422 AC: 103AN: 244338 AF XY: 0.000241 show subpopulations
GnomAD4 exome AF: 0.000171 AC: 245AN: 1435390Hom.: 2 Cov.: 30 AF XY: 0.000127 AC XY: 90AN XY: 711118 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00186 AC: 283AN: 152356Hom.: 0 Cov.: 32 AF XY: 0.00161 AC XY: 120AN XY: 74512 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:4
not specified Benign:3
Gln4981His in Exon 73 of GPR98: This variant is not expected to have clinical si gnificance because it has been identified in 0.7% (20/3016) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS).
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
ADGRV1-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at